1 INDICATIONS AND USAGE YESINTEK is a human interleukin-12 and -23 antagonist indicated for the treatment of: Adult patients with: moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy. ( 1.1 ) active psoriatic arthritis (PsA) . ( 1.2 ) moderately to severely active Crohn’s disease (CD ). ( 1.3 ) moderately to severely active ulcerative

YESINTEK: Roztwór do wstrzykiwań w ampułko-strzykawce 90 mg

6 ADVERSE REACTIONS The following serious adverse reactions are discussed elsewhere in the label: Infections [see Warnings and Precautions (5.1) ] Malignancies [see Warnings and Precautions (5.4) ] Serious Hypersensitivity Reactions [see Warnings and Precautions (5.5) ] Posterior Reversible Encephalopathy Syndrome (PRES) [see Warnings and Precautions (5.6) ] Noninfectious Pneumonia [see Warnings a

4 CONTRAINDICATIONS YESINTEK is contraindicated in patients with clinically significant hypersensitivity to ustekinumab products or to any of the excipients in YESINTEK [see Warnings and Precautions (5.5) ]. Clinically significant hypersensitivity to ustekinumab products or to any of the excipients in YESINTEK. ( 4 )

• Caution should be exercised in patients with history of infection, tuberculosis (TB), cancer, nerve disorder called reversible posterior leukoencephalopathy syndrome (RPLS), poor immunity, flu-like symptoms, received a vaccine, any allergy, who are taking other medications, during pregnancy and breastfeeding. • TB skin test should be performed before using this medication. •

YESINTEK

90 mg, Roztwór do wstrzykiwań w ampułko-strzykawce

INN: Ustekinumabum

Data updated: 2026-04-24

Available in:

🇨🇿🇬🇧🇯🇵🇵🇱🇸🇰

Form

Roztwór do wstrzykiwań w ampułko-strzykawce

Dosage

90 mg

Route

podskórna

Storage

Storage If necessary, the diluted infusion solution may be kept at room temperature up to 25°C (77°F) for up to 4 hours.‍‍‍‍‍‍‍ Storage time at room temperature begins once the diluted solution has been prepared. The infusion should be completed within 4 hours after the dilution in the infusion bag (cumulative time after preparation including the storage and the infusion period). Do not freeze. Discard any unused portion of the infusion solution. Storage and Stability Store YESINTEK vials and prefilled syringes refrigerated between 2°C to 8°C (36°F to 46°F). Store YESINTEK vials upright. Keep the product in the original carton to protect from light until the time of use. Do not freeze. Do not shake. If needed, individual prefilled syringes may be stored at room temperature up to 30°C (86°F) for a maximum single period of up to 30 days in the original carton to protect from light. Record the date when the prefilled syringe is first removed from the refrigerator on the carton in the space provided. Once a syringe has been stored at room temperature, do not return to the refrigerator. Discard the syringe if not used within 30 days at room temperature storage. Do not use YESINTEK after the expiration date on the carton or on the prefilled syringe.

Used to treat:

Arthritis

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.